{
    "url_original": "https://www.wsj.com/articles/mallinckrodt-drug-purchasers-denied-probe-of-chapter-11-asbestos-votes-11637630032?mod=business_minor_pos6",
    "url": "mallinckrodt-drug-purchasers-denied-probe-of-chapter-11-asbestos-votes-11637630032",
    "title": "Mallinckrodt Drug Purchasers Denied Probe of Chapter 11 Asbestos Votes",
    "sub_head": "A creditor group unhappy with the drug company’s pricing wanted claims and votes related to asbestos exposure thrown out",
    "category_1": "Pro Bankruptcy",
    "image_1_url": "https://images.wsj.net/im-439751?width=860&height=573",
    "image_1": "im-439751.jpg",
    "time": "2021-11-22 20:13:00",
    "body": "A creditor group claiming bankrupt drugmaker Mallinckrodt PLC took actions that resulted in price-gouging lost its bid to have an examiner appointed to investigate certain chapter 11 claims and votes related to asbestos exposure.<br />Judge John Dorsey of the U.S. Bankruptcy Court in Wilmington, Del., at a hearing on Monday declined to appoint an examiner to look into ballots cast on Mallinckrodt’s plan to exit chapter 11 bankruptcy on behalf of thousands of asbestos-injury victims represented by personal injury lawyer Thomas Bevan and other law firms."
}